Publicação científica trimestral do CREMERJ - volume 3 - número 1 - 2024

73 Med. Ciên. e Arte , Rio de Janeiro, v.3, n.1, p.60-73, jan-abr 2024 Denervação Simpática Renal no tratamento da Hipertensão Arterial Não Controlada Esmeralci Ferreira e Valerio Fuks 39. Mahfoud F, Schlaich MP, Lobo MD. Device therapy of hypertension. Circ Res 2021;128:1080-99. 40. Barbato E, Azizi M, Schmieder RE, et al. Renal denervation in the management of hypertension in adults. A clinical consensus statement of the ESC Council on Hypertension and the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur Heart J 2023;44:1313-30. doi: 10.1093/eurheartj/ehad054. 41. BöhmM, Kario K, Kandzari DE, Mahfoud F, Weber MA, Schmieder RE, Tsioufis K, Pocock S, Konstantinidis D, Choi JW, East C, Lee DP, Ma A, Ewen S, Cohen DL, Wilensky R, Devireddy CM, Lea J, Schmid A, Weil J, Agdirlioglu T, Reedus D, Jefferson BK, Reyes D, D'Souza R, Sharp ASP, Sharif F, Fahy M, DeBruin V, Cohen SA, Brar S, Townsend RR; SPYRAL HTN-OFF MED Pivotal Investigators. Efficacy of catheter- based renal denervation in the absence of antihypertensive medications (SPYRAL HTN-OFF MED Pivotal): a multicentre, randomised, sham-controlled trial. Lancet. 2020 May 2;395(10234):1444-1451. doi: 10.1016/S0140-6736(20)30554-7. Epub 2020 Mar 29. PMID: 32234534. 42. Kandzari DE, Townsend RR, Kario K, Mahfoud F, Weber MA, Schmieder RE, Pocock S, Tsioufis K, Konstantinidis D, Choi J, East C, Lauder L, Cohen DL, Kobayashi T, Schmid A, Lee DP, Ma A, Weil J, Agdirlioglu T, Schlaich MP, Shetty S, Devireddy CM, Lea J, Aoki J, Sharp ASP, Anderson R, Fahy M, DeBruin V, Brar S, Böhm M; SPYRAL HTN-ON MED Investigators. Safety and Efficacy of Renal Denervation in Patients Taking Antihypertensive Medications. J Am Coll Cardiol. 2023 Nov 7;82(19):1809- 1823. doi: 10.1016/j.jacc.2023.08.045. PMID: 37914510. 43. Azizi M, Schmieder RE, Mahfoud F, et al. Endovascular ultrasound renal denervation to treat hypertension: a multicentre, international, single-blind, randomised, sham-controlled trial. Lancet. 2018 Jun 9; 391(10137): 2335-2345. 44. Azizi M, Schmieder RE, Mahfoud F, Weber MA, Daemen J, Lobo MD, Sharp ASP, Bloch MJ, Basile J, Wang Y, Saxena M, Lurz P, Rader F, Sayer J, Fisher NDL, Fouassier D, Barman NC, Reeve-Stoffer H, McClure C, Kirtane AJ; RADIANCE-HTN Investigators. Six-Month Results of Treatment-Blinded Medication Titration for Hypertension Control After Randomization to Endovascular Ultrasound Renal Denervation or a Sham Procedure in the RADIANCE-HTN SOLO Trial. Circulation. 2019 May 28;139(22):2542-2553. doi: 10.1161/CIRCULATIONAHA.119.040451. Epub 2019 Mar 17. PMID: 30880441. 45. Azizi M, Mahfoud F, Weber MA, Sharp ASP, Schmieder RE, Lurz P, Lobo MD, Fisher NDL, Daemen J, Bloch MJ, Basile J, Sanghvi K, Saxena M, Gosse P, Jenkins JS, Levy T, Persu A, Kably B, Claude L, Reeve-Stoffer H, McClure C, Kirtane AJ; RADIANCE-HTN Investigators. Effects of Renal Denervation vs Sham in Resistant Hypertension After Medication Escalation: Prespecified Analysis at 6 Months of the RADIANCE-HTN TRIO Randomized Clinical Trial. JAMA Cardiol. 2022 Dec 1;7(12):1244-1252. doi: 10.1001/jamacardio.2022.3904. PMID: 36350593; PMCID: PMC9647563. 46. Azizi M, Saxena M, Wang Y, et al. Endovascular ultrasound renal denervation to treat hypertension: the RADIANCE II randomized clinical trial. JAMA 2023;329:651-61. 47. Lambert GW, Hering D, Esler MD, Marusic P, Lambert EA, Tanamas SK, Shaw J, KrumH, Dixon JB, Barton DA, Schlaich MP. Health-related quality of life after renal denervation in patients with treatment-resistant hypertension. Hypertension. 2012 Dec;60(6):1479-84. doi: 10.1161/HYPERTENSIONAHA.112.200865. Epub 2012 Oct 15 48. Medtronic receives FDA approval for renal denervation device. [acesso em 2024 jan 16]. Disponível em: <https://www.medtechdive.com/news/medtronic-fda-approval-symplicity-renal-denervation/700316/ > 49. Prado GM, Armaganijan LV, Staico R, Lopes RD. Denervação renal no tratamento de arritmias ventriculares: revisão sistemática e metanálise. Arq. Bras. Cardiol.; 115(5 supl.1): 19-19, nov. 2020. 50. Linz D, Mahfoud F, Schotten U, et al. Renal sympathetic denervation suppresses post apneic blood pressure rises and atrial fibrillation in a model for sleep apnea. Hypertension 2012;60:172-8.